ViroPharma and Schering-Plough Finalize Pleconaril License Agreement
November 03, 2004 09:20 ET
|
ViroPharma Incorporated
EXTON, Pa., Nov. 3, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that Schering-Plough Corporation (NYSE:SGP) and ViroPharma have finalized the license agreement under...
ViroPharma to Host Conference Call with Investors to Discuss the Acquisition of U.S. Vancocin Brand from Lilly
October 18, 2004 15:25 ET
|
ViroPharma Incorporated
EXTON, Pa., Oct. 18, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) will host a conference call with investors and webcast to discuss the company's agreement to acquire all rights to the...
ViroPharma Incorporated to Acquire U.S. Vancocin Brand from Lilly
October 18, 2004 15:20 ET
|
ViroPharma Incorporated
EXTON, Pa., Oct. 18, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by...
ViroPharma Maintains Nasdaq National Market Listing
September 15, 2004 09:40 ET
|
ViroPharma Incorporated
EXTON, Pa., Sept. 15, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it was notified on September 14, 2004 that it has evidenced compliance with all requirements for...
Joshua M. Tarnoff Joins ViroPharma as Vice President, Commercial Operations
August 30, 2004 10:31 ET
|
ViroPharma Incorporated
EXTON, Pa., Aug. 30, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that Joshua M. Tarnoff has joined the company as vice president, commercial operations. Mr. Tarnoff will...
ViroPharma Announces Agreement with SIGA Technologies for Sale of Biodefense Assets
August 25, 2004 08:30 ET
|
ViroPharma Incorporated
EXTON, Pa., Aug. 25, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced that it has sold certain of its early stage biodefense assets, including compounds, assays and other...
Schering-Plough Exercises Option to License ViroPharma's Intranasal Pleconaril
August 23, 2004 08:30 ET
|
ViroPharma Incorporated
KENILWORTH, N.J. and EXTON, Pa., Aug. 23, 2004 (PRIMEZONE) -- Schering-Plough Corporation (NYSE:SGP) and ViroPharma Incorporated (NASDAQ:VPHM) today announced that Schering-Plough has exercised its...
ViroPharma Incorporated Reports Second Quarter Financial Results
August 05, 2004 18:36 ET
|
ViroPharma Incorporated
EXTON, Pa., Aug. 5, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter and six months ended June 30, 2004.
For the quarter ended June 30,...
ViroPharma Initiates Maribavir Phase 2 Program In Bone Marrow Transplant Patients
July 27, 2004 09:00 ET
|
ViroPharma Incorporated
EXTON, Pa., July 27, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the initiation of its Phase 2 clinical program for maribavir, an oral antiviral drug that inhibits...
ViroPharma Receives Preliminary Court Approval for Settlement of Class Action Litigation
July 27, 2004 09:00 ET
|
ViroPharma Incorporated
EXTON, Pa., July 27, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the United States District Court for the Eastern District of Pennsylvania has issued an order...